Inventor
VANOVER KIMBERLY
US25 patents
⚠️ This page may combine multiple inventors who share the name “VANOVER KIMBERLY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTRA CELLULAR THERAPIES INC
24 patentsUS9428506B2Aug 30, 2016
Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
INTRA CELLULAR THERAPIES INC82 citations99
US11124514B2Sep 21, 2021
Compositions and methods
INTRA CELLULAR THERAPIES INC40 citations98
US11053245B2Jul 6, 2021
Methods
INTRA CELLULAR THERAPIES INC40 citations98
US11026951B2Jun 8, 2021
Methods of treating bipolar disorder
INTRA CELLULAR THERAPIES INC38 citations98
US10960009B2Mar 30, 2021
Methods of treating schizophrenia and depression
INTRA CELLULAR THERAPIES INC39 citations98
US10960010B2Mar 30, 2021
Pharmaceutical compositions for sustained or delayed release
INTRA CELLULAR THERAPIES INC38 citations98
US10322134B2Jun 18, 2019
Methods
INTRA CELLULAR THERAPIES INC49 citations98
US10245260B2Apr 2, 2019
Organic compounds
INTRA CELLULAR THERAPIES INC38 citations98
US9956227B2May 1, 2018
Method for the treatment of residual symptoms of schizophrenia
INTRA CELLULAR THERAPIES INC78 citations98
US11958852B2Apr 16, 2024
Compounds and methods
INTRA CELLULAR THERAPIES INC11 citations94
US11427587B2Aug 30, 2022
Organic compounds
INTRA CELLULAR THERAPIES INC31 citations94
US11376249B2Jul 5, 2022
Organic compounds
INTRA CELLULAR THERAPIES INC29 citations94
US10799500B2Oct 13, 2020
Organic compounds
INTRA CELLULAR THERAPIES INC28 citations94
US12090155B2Sep 17, 2024
Methods
INTRA CELLULAR THERAPIES INC13 citations86
US11844757B2Dec 19, 2023
Organic compounds
INTRA CELLULAR THERAPIES INC10 citations86
US11773095B2Oct 3, 2023
Organic compounds
INTRA CELLULAR THERAPIES INC9 citations86
US11753419B2Sep 12, 2023
4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders
INTRA CELLULAR THERAPIES INC6 citations86
US12122792B2Oct 22, 2024
Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders
INTRA CELLULAR THERAPIES INC3 citations75
US12173004B2Dec 24, 2024
Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs
INTRA CELLULAR THERAPIES INC1 citations73
US12565499B2Mar 3, 2026
Compounds and methods
INTRA CELLULAR THERAPIES INC0 citations62
US12440489B2Oct 14, 2025
Organic compounds
INTRA CELLULAR THERAPIES INC0 citations62
US12410195B2Sep 9, 2025
Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders
INTRA CELLULAR THERAPIES INC0 citations62
US12195463B2Jan 14, 2025
Organic compounds
INTRA CELLULAR THERAPIES INC0 citations62
US12325726B2Jun 10, 2025
Organic compounds
INTRA CELLULAR THERAPIES INC1 citations60